|Articles|January 15, 2021

Supplements and Featured Publications

  • The Effect of Intravenous Taxane-Related Toxicities on Metastatic Breast Cancer Disease Treatment and Healthcare Costs

The Effect of Intravenous Taxane-Related Toxicities on Metastatic Breast Cancer Disease Treatment and Healthcare Costs

This publication was supported by Athenex Oncology.

This AJMC® Clinical Brief explores the effect that taxane-related toxicities have on the treatment of metastatic breast cancer and healthcare costs, including the economic and clinical burdens. This publication also includes thought leader perspectives from the Medical Director of Managed Care at OneOncology, John Fox, MD, MHA.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo